help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sumitani, S.
Right arrow Articles by Klip, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sumitani, S.
Right arrow Articles by Klip, A.
Endocrinology Vol. 138, No. 3 1029-1034
Copyright © 1997 by The Endocrine Society


Articles

Insulin Regulation and Selective Segregation with Glucose Transporter-4 of the Membrane Aminopeptidase vp165 in Rat Skeletal Muscle Cells1

Satoru Sumitani, Toolsie Ramlal, Romel Somwar, Susanna R. Keller and Amira Klip

Division of Cell Biology (S.S., T.R., R.S., A.K.), The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8; and the Department of Biochemistry, Dartmouth Medical School (S.R.K.), Hanover, New Hampshire 03755

Address all correspondence and requests for reprints to: Amira Klip, Ph.D., Division of Cell Biology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8. E-mail amira{at}sickkids.on.ca


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
vp165, a recently described member of the family of zinc-dependent membrane aminopeptidases, is a major constituent of glucose transporter-4 (GLUT4)-containing vesicles in adipocytes and skeletal muscle. Here we show that vp165 is expressed in L6 myoblasts and increases by 4.3-fold during differentiation into myotubes. The localization of vp165 in L6 myotubes was assessed by immunoblotting subcellular fractions from basal and insulin-stimulated cells and was compared to the distribution of GLUT4. vp165 and GLUT4 were mainly concentrated in the low density microsomal membranes under basal conditions. Upon stimulation with insulin, vp165 and GLUT4 were redistributed from the low density microsomes to the plasma membrane. The majority of vp165 was found in immunoisolated GLUT4-containing vesicles, and vice versa, the majority of GLUT4 was detected in immunoisolated vp165-containing vesicles. In contrast, the two other glucose transporter isoforms expressed in L6, GLUT1 and GLUT3, were excluded from GLUT4- and vp165-containing vesicles. These results suggest that in rat skeletal muscle cells, vp165 and GLUT4 cosegregate to the same intracellular compartment and that this is distinct from the compartment containing GLUT1 and GLUT3.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
IN FAT AND muscle cells, insulin stimulates glucose uptake largely by the recruitment of glucose transporters to the cell surface (1, 2, 3). This is most likely achieved by the insulin-regulated traffic of specialized intracellular membrane structures containing the glucose transporter isoform GLUT4 (GLUT4-containing vesicles) to the plasma membrane (PM) (4, 5, 6). To further understand the basic mechanisms of this translocation, the polypeptide composition of GLUT4-containing vesicles is being investigated by several groups. Proteins that have been identified as components of these vesicles are phosphatidylinositol 4-kinase (7), secretory carrier membrane proteins (8), also called GTV3 for glucose transporter vesicle-associated proteins (9), vesicle-associated membrane protein-2 (10, 11), cellubrevin (11), and some low mol wt GTP-binding proteins, including Rab4 (12, 13). In addition, it has been shown that GLUT4-containing vesicles isolated from rat adipocytes (14), 3T3-L1 adipocytes (15, 16), and rat skeletal muscle cells (5) contain a prominent polypeptide migrating at about 160 kDa on SDS-polyacrylamide gels, which redistributes to the cell surface upon insulin stimulation. Mastick et al. (17) have purified this polypeptide from rat adipocytes (designated vp165) and suggested it to be a novel protein. Kandror et al. (18) also purified the polypeptide from rat adipocytes (designated gp160) and obtained evidence that it is an aminopeptidase (19). Cloning of the complementary DNA encoding vp165 and further characterization of vp165 demonstrated that it is a new member of the family of zinc-dependent membrane aminopeptidases (20). vp165 was shown to be concentrated in GLUT4-containing vesicles of rat adipocytes (17, 18, 20), rat skeletal muscle (21, 22), and mouse 3T3-L1 adipocytes (23). Northern blot analysis and immunoblotting showed that the expression of vp165 is not restricted to insulin-responsive tissues and is present at comparable levels in all major tissues except liver, where its amounts are comparatively low (20).

In the present study we have characterized vp165 in L6 cells, a rat skeletal muscle cell line that has been used extensively for the investigation of insulin-stimulated GLUT4 translocation (24, 25, 26). We found that the expression of vp165 was up-regulated during differentiation of myoblasts into myotubes. vp165 localized to the same intracellular compartments as GLUT4, and insulin caused translocation of vp165 from the intracellular pool to the cell surface, similar to GLUT4. Finally, we show that the vp165 compartment does not contain the other glucose transporters of L6 cells, GLUT1 and GLUT3.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Materials
{alpha}MEM, FBS, and other tissue culture reagents were purchased from Life Technologies (Gaithersburg, MD). 125I-Labeled protein A, 125I-labeled sheep antimouse IgG, Fc fragment-specific affinity-purified goat antimouse IgG, and Fc fragment-specific affinity-purified goat antirabbit IgG were obtained from ICN (Costa Mesa, CA). Dynabeads M-500 magnetic subcellular beads were purchased from Dynal (Oslo, Norway). Polyclonal antisera against the C-terminal sequence of GLUT4 or the C-terminal sequence of GLUT1 were obtained from East Acres Biologicals. Polyclonal antimouse GLUT3 antibody was a gift from Dr. I. Simpson (NIH, Bethesda, MD). Monoclonal antibody against GLUT4 (1F8) was obtained from Genzyme Diagnostics (Cambridge, MA). Mouse IgG and rabbit IgG, used as a control for immunoisolation, were purchased from Sigma Chemical Co. (St. Louis, MO). An affinity-purified polyclonal antibody against vp165 was raised against the N-terminal 109 amino acids of rat vp165 (20). Anti-{alpha}1-subunit Na+/K+-ATPase monoclonal antibody (6H) was a gift from Dr. M. Caplan (Yale University, New Haven, CT). All other reagents were of analytical grade.

Cell culture
A clonal line of L6 muscle cells selected for high fusion potential was grown in {alpha}MEM containing 2% FBS; these cells were allowed to fuse and differentiate as described previously (27, 28). Myoblasts were studied just before reaching confluency before any evidence of differentiation (cell fusion). Fully differentiated myotubes were studied at more than 90% maximal fusion. For subcellular fractionation, L6 myotubes were serum deprived for 5 h and then incubated with or without 100 nM insulin (Humulin R) for 30 min at 37 C and subjected to subcellular fractionation.

Membrane isolation
Subcellular fractionation of L6 myotubes was carried out according to the method of Piper et al. for 3T3-L1 adipocytes (29) to obtain PM, high density microsome (HDM), and low density microsome (LDM). Briefly, after pretreatment with or without insulin, cells were rinsed with cold {alpha}MEM and scraped with a rubber policeman. The cells were pelleted, resuspended in homogenization buffer (250 mM sucrose, 2 mM EGTA, 5 mM NaN3, and 20 mM HEPES, pH 7.4, with 1 µM leupeptin, 1 µM pepstatin A, 10 µM E-64, and 200 µM phenylmethylsulfonylfluoride), and homogenized with 10 strokes through an EMBL Cell Cracker (clearance, 0.0016 in.). The homogenate was centrifuged at 19,000 x g for 20 min, the pellet was then resuspended in 5 ml homogenization buffer and layered onto 1.12 M sucrose, 1 mM EDTA, and 20 mM HEPES, pH 7.4, and centrifuged at 100,000 x g for 60 min. The membranes recovered on top of the 1.12 M sucrose were resuspended in homogenization buffer and pelleted at 40,000 x g for 20 min. The pelleted membranes were designated PM based on marker enzyme composition. The supernatant of the 19,000 x g spin was sedimented at 41,000 x g for 20 min to yield HDM as the pelleted material. The supernatant was centrifuged at 180,000 x g for 75 min to pellet the LDM. Total membranes of L6 myoblasts and myotubes were prepared as described previously (30). Subcellular fractionation of rat skeletal muscle was carried out as described previously for hindquarter muscle (3, 31). The F35 fraction of rat skeletal muscle was previously shown to be enriched in GLUT4 (3, 31, 32). Protein concentration was determined with a BCA kit (Pierce Chemical Co., Rockford, IL) according to the manufacturer’s instructions.

Immunoisolation of GLUT4- or vp165-containing vesicles
Immunoisolation of GLUT4-containing vesicles was performed using the monoclonal antibody IF8 immobilized on M-500 magnetic beads. Coupling of the secondary antibody to the beads was carried out according to the manufacturer’s instructions. Briefly, 4 x 108 beads were washed twice with PBS, pH 7.4, and then incubated with 0.4 mg Fc fragment-specific affinity-purified goat antimouse IgG in 0.1 M borate, pH 9.4, at 37 C for 20 h. The beads were rinsed twice with PBS containing 0.1% BSA, incubated with 0.2 M Tris-HCl, pH 8.5, with 0.1% BSA for 4 h at 37 C, and washed in PBS-BSA for 5 min at 4 C. The coated beads were subjected to coupling of primary antibody. Two micrograms of 1F8 or control mouse IgG were incubated with the coated beads in PBS-BSA at 4 C for 16–18 h under constant rotation and washed four times with PBS-BSA. L6 myotubes were fractionated to remove nuclei, mitochondria, and PM, but without sedimenting LDM (33). The supernatant containing LDM was adjusted to 100 mM potassium phosphate, pH 7.4, and the protein concentration was measured. An aliquot containing 200 µg protein, adjusted to 1 ml with PBS, 2 mM EDTA, was added to the coated beads and incubated for 16–18 h at 4 C under constant rotation. The supernatant was removed, the beads were washed three times with ice-cold PBS without BSA, and the resulting supernatants were combined with the first one. Pooled supernatants were centrifuged at 200,000 x g for 60 min to sediment membranes. Immunoisolation of vp165-containing vesicles was performed exactly as described above, except that affinity-purified antirabbit IgG was coupled to magnetic beads, and 8 µg affinity-purified vp165 antibody or control rabbit IgG were used as the primary antibody. The sedimented membranes were solubilized in 2 x Laemmli’s sample buffer (34) containing 8 M urea (sample named SN). The material bound to the beads was equally solubilized in 2 x Laemmli’s sample buffer containing 8 M urea (sample named Pt).

Immunoblotting
Samples were solubilized in Laemmli’s sample buffer, resolved by SDS-PAGE, and transferred onto polyvinylidene difluoride membranes. Immunoblotting was carried out as described previously (31) using anti-{alpha}1 Na+/K+-ATPase monoclonal antibody (1:1000), polyclonal antiserum against GLUT4 (1:1000), GLUT1 (1:2000), GLUT3 (1:2000), and affinity-purified antibody against vp165 (1 µg/ml). Immunoreactive bands were quantified by laser scanning densitometry of the autoradiograms.

Statistics
Throughout the study, Student’s paired t test was applied. This test analyzes the mean of differences between two conditions, such as control and insulin-treated, even if the control is assigned a value of 1.0. The test gathers the difference between the two conditions from each experiment and then analyzes the average of the differences and determines its significance.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Expression of vp165 in L6 myoblasts and myotubes
We have shown previously that GLUT4 is barely detectable in L6 myoblasts and that its expression is turned on during differentiation into myotubes (27, 28). To examine the expression of vp165 and its regulation during differentiation, we prepared total membranes of L6 myoblasts and myotubes and immunoblotted them for vp165. The antibody against vp165 reacted with a single band migrating at 165 kDa in both myoblasts and myotubes. In Fig. 1AGo, immunoblots of vp165 in L6 myoblasts and myotubes are compared to immunoblots of GLUT4 and {alpha}1 Na+/K+-ATPase. The F35 fraction of rat skeletal muscle was also probed for positive control of blotting. Consistent with previous results, the immunoreactive band of GLUT4 was hardly seen in myoblasts even after long exposure of the film, but it increased markedly after differentiation into myotubes. In contrast, a small, but detectable, amount of vp165 protein was present in myoblasts, and like GLUT4, the amount of vp165 increased substantially during differentiation into myotubes. Densitometric analysis of the immunoreactive bands revealed that the amount of vp165 was greater by 4.3 ± 0.7-fold in myotubes than in myoblasts (P < 0.01; n = 3; Fig. 1BGo). Consistent with our previous reports (27, 28), GLUT4 was 9.6 ± 0.8-fold greater in myotubes than in myoblasts (P < 0.01; n = 3). In contrast, the expression of {alpha}1 Na+/K+-ATPase did not change during differentiation (1.0 in myoblasts vs. 1.0 ± 0.1 in myotubes). These results indicate that the expression of vp165 is up-regulated during differentiation of L6 skeletal muscle cells.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 1. Effect of differentiation on the expression of vp165 in L6 skeletal muscle cells. Fifteen micrograms of F35 fraction of rat skeletal muscle (F35) and total membranes of L6 myoblasts (Mb) or myotubes (Mt) were separated on 10% SDS-polyacrylamide gels and immunoblotted with antibodies against vp165, GLUT4, and {alpha}1-subunit of Na+/K+-ATPase as described in Materials and Methods. Representative immunoblots are shown in A. The protein contents of vp165, GLUT4, and {alpha}1-subunit of Na+/K+-ATPase ({alpha}1) in myoblasts (open bars) and myotubes (solid bars) were quantified and are presented in B. Results are expressed in relative units, with the reading in myoblasts assigned a value of 1.0. Results are the mean ± SE of three separate experiments. SE bars in myoblasts are too small to be apparent. Asterisks denote a significant difference (P < 0.01) relative to the value in myoblasts.

 
Distribution of vp165 in subcellular fractions from basal and insulin-stimulated L6 myotubes
In rat adipocytes (17, 18) and mouse 3T3-L1 adipocytes (23) vp165 is almost exclusively located in LDM under basal conditions and redistributes to the PM in response to insulin. To examine the subcellular distribution of vp165 in L6 myotubes, we prepared membrane fractions from basal and insulin-stimulated cells as originally described by Piper et al. (29) for 3T3-L1 adipocytes. The relative amounts of vp165, GLUT4, and {alpha}1 Na+/K+-ATPase in the three distinct membrane fractions, LDM, HDM, and PM, were determined by immunoblotting. Densitometric analysis of 10 independent experiments shows that relative enrichments of vp165 per mg protein in HDM and LDM were 3.71 ± 0.60 and 1.98 ± 0.54, respectively, compared to that in PM. On the average, the subcellular fractionation of one confluent 10-cm dish of L6 myotubes yielded approximately 107 µg protein from PM, 47 µg protein from HDM, and 131 µg protein from LDM. When this yield of protein from PM, HDM, and LDM fractions was considered, the relative amounts of vp165 in HDM and LDM compared to that in PM were 1.76 ± 0.27 and 2.54 ± 0.60, respectively. By a similar calculation, the relative recoveries of GLUT4 in the PM, HDM, and LDM were 1.00, 1.41 ± 0.84, and 3.34 ± 0.80, respectively (Table 1Go). In contrast, the relative enrichment of {alpha}1-subunit of Na+/K+-ATPase, a PM protein, per mg protein from PM was approximately 20 times greater than that from LDM, indicating that the majority of the PM was recovered in the PM fraction and that the contamination of LDM with PM is low. Thus, both vp165 and GLUT4 were found mainly in the LDM under basal conditions.


View this table:
[in this window]
[in a new window]
 
Table 1. Relative yield of vp165, GLUT4, and {alpha}1 Na+/K+-ATPase in subcellular fractions of L6 myotubes

 
Subcellular membrane fractions were prepared from insulin-treated and control cells and probed with antibodies against vp165 and GLUT4 (Fig. 2AGo). Insulin caused statistically significant decreases in both proteins in the LDM and statistically significant increases in the PM. The immunoreactivity of the bands was quantified by laser scanning densitometry, and the recovery of each protein in PM, HDM, and LDM was calculated (Fig. 2BGo). In 10 independent experiments, the content of vp165 was augmented by 33 ± 13% in PM after insulin stimulation and was reduced by 51 ± 6% in LDM. Similarly, the content of GLUT4 protein increased by 36 ± 13% in the PM and decreased by 27 ± 5% in the LDM. There were not statistically significant changes in GLUT4 or vp165 in the HDM. Insulin did not affect the distribution of {alpha}1-subunit of Na+/K+-ATPase in any of the fractions (Figs. 2AGo, bottom panel, and B).



View larger version (29K):
[in this window]
[in a new window]
 
Figure 2. Effect of insulin on the subcellular distribution of vp165 in L6 myotubes. Ten micrograms of PM, HDM, and LDM from untreated (C) or insulin-treated (I) L6 myotubes were separated on 10% SDS-polyacrylamide gels and immunoblotted with antibodies against vp165, GLUT4, and {alpha}1-subunit of Na+/K+-ATPase. Representative immunoblots are presented in A. The protein recoveries of vp165 (open bars), GLUT4 (dotted bars), and {alpha}1-subunit of Na+/K+-ATPase (solid bars) were calculated and are presented in B. Results are expressed in relative units, with the data in the corresponding fractions of untreated cells assigned a value of 1.0. Results are the mean ± SE of 10 separate experiments. Asterisks (*, P < 0.05; **, P < 0.01) denote a significant difference compared to the values in the untreated cells, assessed by Student’s paired t test.

 
Topological relations of vp165 to glucose transporters
To address the question of whether vp165 is localized in GLUT4-containing vesicles in L6 myotubes, we immunoisolated GLUT4-containing vesicles using the monoclonal antibody 1F8 immobilized on magnetic beads and examined them for the presence of vp165 by immunoblotting. Figure 3Go shows that a substantial portion of vp165 was immunoisolated with GLUT4-containing vesicles. The amounts of immunodetectable GLUT4 protein sedimented nonspecifically by the nonimmune IgG was subtracted from the amount immunoprecipitated with 1F8, and this difference was then divided by the amount of GLUT4 protein immunoprecipitated with 1F8. By this calculation, 91 ± 3% (mean ± SE; n = 4) of the GLUT4 in the pellet was specifically immunoprecipitated with 1F8. The efficiency of the immunoisolation of vesicles is defined as the ratio of the amount of antigen immunoprecipitated with 1F8 to the total immunoprecipitable antigen, which is the sum of the amount left in the SN and the amount bound to the 1F8. The efficiency of the immunoisolation of GLUT4-containing vesicles was 83 ± 5%, and that of vp165 coimmunoisolated with GLUT4-containing vesicles was 67 ± 12% (n = 4). Two other isoforms of glucose transporter, GLUT3 and GLUT1, are expressed in L6 myotubes (28). Although these isoforms also translocate to the cell surface in response to insulin (25), it has not been previously explored whether all glucose transporter isoforms localize to the same intracellular vesicles. Therefore, we searched for GLUT1 and GLUT3 on the immunoisolated GLUT4-containing vesicles. As shown in Fig. 3Go, the majority of GLUT1 and GLUT3 were excluded from the immunoisolated GLUT4-containing vesicles.



View larger version (57K):
[in this window]
[in a new window]
 
Figure 3. Characterization of GLUT4-containing vesicles. GLUT4-containing vesicles were immunoisolated as described in Materials and Methods, using either monoclonal antibody 1F8 (1F8), or nonimmune mouse IgG (IgG). The materials bound to the beads (Pt; i.e. adsorbed membranes) and sedimented supernatant (SN; i.e. nonadsorbed membranes) were separated on 7.5% SDS-polyacrylamide gels and immunoblotted for GLUT4, vp165, GLUT3, and GLUT1. Representative immunoblots of four separate experiments for each immunoisolation are shown. See text for averaged results.

 
To further confirm the colocalization of vp165 and GLUT4, we immunoisolated vp165-containing vesicles and examined them for the presence of GLUT4 (Fig. 4Go). The specificity of the immunoisolation of vp165-containing vesicles was 90 ± 4%. As can be appreciated from the figure, vp165 was almost completely immunoisolated. In four separate experiments, the efficiency of immunoisolation of vp165-containing vesicles was 93 ± 3%. Importantly, 90 ± 3% of GLUT4 was simultaneously immunoisolated with vp165-containing vesicles. In contrast, GLUT1 and GLUT3 were excluded from these vesicles (Fig. 4Go).



View larger version (62K):
[in this window]
[in a new window]
 
Figure 4. Characterization of vp165-containing vesicles. vp165-containing vesicles were immunoisolated as described in Materials and Methods using either affinity-purified vp165 antibody (vp) or nonimmune rabbit IgG (IgG). The materials bound to the beads (Pt) and sedimented supernatant (SN) were separated on 7.5% SDS-polyacrylamide gels and probed for the presence of vp165, GLUT4, GLUT3, and GLUT1. Representative immunoblots of seven separate experiments are shown. See text for averaged results.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We have previously shown that in L6 rat skeletal muscle cells, the expression of GLUT4 is regulated during differentiation of myoblasts into myotubes (27, 28). As shown in Fig. 1Go, the amount of vp165 also markedly increased during differentiation into myotubes, but in contrast to GLUT4, a measurable amount of vp165 was present in myoblasts. These results are consistent with the observations in mouse 3T3-L1 cells, where the regulation of vp165 expression was also different from that of GLUT4, and vp165 was also present in the undifferentiated fibroblasts (23).

Insulin causes translocation of vp165 from the LDM to the PM concomitantly with GLUT4 in rat adipocytes (17, 18) and in mouse 3T3-L1 adipocytes (23). However, in skeletal muscle, there has been no report describing the translocation of vp165 to the PM after insulin stimulation. Coderre et al. demonstrated that after insulin stimulation in vivo, the amount of vp165 (gp160) is reduced in an insulin-sensitive intracellular pool of rat skeletal muscle membranes containing GLUT4, indicating the redistribution of this molecule (22). However, the increase in vp165 in the PM in response to insulin was not shown. In the present study we performed subcellular fractionation of L6 myotubes to demonstrate translocation of vp165 to the PM after insulin stimulation. This system has been used previously to study the mechanisms of insulin-induced translocation of GLUT4 in skeletal muscle cells. We used a subcellular fractionation procedure that was originally developed for 3T3-L1 adipocytes (29). This method enabled us to obtain a more pure PM fraction compared to the previously used method (30). This is supported by the observation that the relative distribution of {alpha}1 Na+/K+-ATPase, a PM marker, determined by densitometric analysis of the immunoreactive bands on the autoradiograms is 20 times greater in the PM compared to the LDM. Also, Fig. 2BGo shows that the amount of GLUT4 increased by 36 ± 13% in the PM and decreased by 27 ± 5% in the LDM in response to insulin. These values are comparable to the increase in cell surface GLUT4 in response to insulin detected by photolabeling (35), corroborating the idea that this method for subcellular fractionation of L6 myotubes is suitable to detect insulin-dependent translocation of proteins from the LDM to the PM.

In insulin-responsive cells, namely heart, fat, and skeletal muscle, GLUT4 glucose transporters are located in specialized intracellular membrane vesicles that translocate to the cell surface upon insulin stimulation (4, 5, 6). In agreement with observations made in rat adipocytes (17, 18, 21), rat skeletal muscle (21, 22) and mouse 3T3-L1 adipocytes (23), the majority of vp165 in L6 myotubes was colocalized to GLUT4-containing vesicles. Under conditions where 83 ± 5% of GLUT4-containing vesicles were efficiently immunoisolated, 67 ± 12% of vp165 was simultaneously immunoisolated. Although these values are not statistically different, these results suggest that there may be some intracellular membrane vesicles that contain vp165, but are devoid of GLUT4. Conversely, 90 ± 3% of GLUT4 was coimmunoisolated when 93 ± 3% of vp165-containing vesicles were immunoisolated.

Consistent with a previous report that GLUT1 is excluded from GLUT4-containing vesicles in rat skeletal muscle (21), GLUT1 was not detected in GLUT4-containing vesicles of L6 myotubes. In addition, we demonstrated that GLUT3, another glucose transporter isoform expressed in L6, is also excluded from GLUT4-containing vesicles (Fig. 3Go). Exclusion of GLUT1 and GLUT3 from GLUT4-containing vesicles was further confirmed by the finding that GLUT1 and GLUT3 were not detected on vp165-containing vesicles when the majority of GLUT4 was coimmunoprecipitated with vp165-containing vesicles. Taken together, these findings suggest that vp165 and GLUT4 cosegregate to the same intracellular compartment, whereas GLUT1 and GLUT3 are excluded from this compartment. The results also demonstrate that in L6 myotubes there is a specific compartment of GLUT4 that is distinct from the compartments populated by the other glucose transporters.

In conclusion, this study shows that in L6 cells, vp165 and GLUT4 colocalize to the same intracellular compartment and are regulated by insulin in a similar fashion. vp165 can, therefore, serve as an excellent marker to study insulin-elicited translocation to the cell surface in these cells. The physiological function of vp165 and its role in established insulin effects are currently not known, but given that vp165 is regulated by insulin like GLUT4 and that vp165 colocalizes with GLUT4, but not with GLUT1 or GLUT3, the consequences of vp165 translocation may be as far reaching as they are for GLUT4 in mediating the anabolic responses to the hormone.


    Acknowledgments
 
We thank Dr. M. Caplan for the anti-{alpha}1-subunit of Na+/K+-ATPase antibody, and Dr. I. Simpson for the GLUT3 antibody.


    Footnotes
 
1 This work was supported by Grant MT-7307 from the Medical Research Council (to A.K.). Back

Received July 18, 1996.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Cushman S, Wardzala L 1980 Potential mechanism of insulin action on glucose transport in the isolated rat adipose cells. Apparent translocation of intracellular transport system to the plasma membrane. J Biol Chem 255:4758–4762[Free Full Text]
  2. Suzuki K, Kono T 1980 Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci USA 77:2542–2545[Abstract/Free Full Text]
  3. Klip A, Ramlal T, Young DA, Holloszy JO 1987 Insulin-induced translocation of glucose transporters in rat hindlimb muscles. FEBS Lett 224:224–230[CrossRef][Medline]
  4. Robinson LJ, James DE 1992 Insulin-regulated sorting of glucose transporters in 3T3–L1 adipocytes. Am J Physiol 263:E383–E393
  5. Rodnick KJ, Slot JW, Studelska DR, Hanpeter DE, Robinson LJ, Geuze HJ, James DE 1992 Immunocytochemical and biochemical studies of GLUT4 in rat skeletal muscle. J Biol Chem 267:6278–6285[Abstract/Free Full Text]
  6. Slot JW, Geuze HJ, Gigengack S, Lienhard GE, James DE 1991 Immuno-localization of the insulin regulatable glucose transporter in brown adipose tissue of the rat. J Cell Biol 113:123–135[Abstract/Free Full Text]
  7. Del Vecchio RL, Pilch PF 1991 Phosphatidylinositol 4-kinase is a component of glucose transporter (GLUT4)-containing vesicles. J Biol Chem 266:13278–13283[Abstract/Free Full Text]
  8. Laurie SM, Cain CC, Lienhard GE, Castle JD 1993 The glucose transporter GLUT4 and secretory carrier membrane proteins (SCAMPs) colacalize in rat adipocytes and partially segregate during insulin stimulation. J Biol Chem 268:19110–19117[Abstract/Free Full Text]
  9. Thoidis G, Kotliar N, Pilch PF 1993 Immunological analysis of GLUT4-enriched vesicles: identification of novel proteins regulated by insulin and diabetes. J Biol Chem 268:11691–11696[Abstract/Free Full Text]
  10. Cain CC, Trimble WT, Lienhard GE 1992 Members of the VAMP family of synaptic vesicle proteins are components of glucose transporter-containing vesicles from rat adipocytes. J Biol Chem 267:11681–11684[Abstract/Free Full Text]
  11. Volchuk A, Sargeant R, Sumitani S, Liu Z, He L, Klip A 1995 Cellubrevin is a resident protein of insulin-sensitive GLUT4 glucose transporter vesicles in 3T3–L1 adipocytes. J Biol Chem 270:8223–8240
  12. Cormont M, Tanti J-F, Gremeaux T, Van Obberghen E, Le Marchand-Brustel Y 1991 Subcellular distribution of low molecular weight guanosine-triphosphate-binding proteins in adipocytes: colocalization with the glucose transporter Glut4. Endocrinology 129:3343–3350[Abstract]
  13. Cormont M, Tanti J-F, Zahraoui A, Van Obberghen E, Tavitian A, Le Marchand-Brustel Y 1993 Insulin and okadaic acid induce Rab4 redistribution in adipocytes. J Biol Chem 268:19491–19497[Abstract/Free Full Text]
  14. Zorzano A, Wilkinson W, Kotliar N, Thoidis G, Wadzinski BE, Ruoho AE, Pilch PF 1989 Insulin-regulated glucose uptake in rat adipocytes is mediated by two glucose transporter isoforms present in at least two vesicle populations. J Biol Chem 264:12358–12363[Abstract/Free Full Text]
  15. Brown SJ, Gould GW, Davies A, Baldwin SA, Lienhard GE, Gibbs EM 1988 Characterization of vesicles containing insulin-responsive intracellular glucose transporters isolated from 3T3–L1 adipocytes by an improved procedure. Biochim Biophys Acta 971:339–350[Medline]
  16. Calderhead DM, Kitagawa K, Tanner LI, Holman GD, Lienhard GE 1990 Insulin regulation of the two glucose transporters in 3T3–L1 adipocytes. J Biol Chem 265:13800–13808[Abstract/Free Full Text]
  17. Mastick CC, Aebersold R, Lienhard GE 1994 Characterization of a major protein in GLUT4 vesicles. Concentration in the vesicles and insulin-stimulated translocation to the plasma membrane. J Biol Chem 269:6089–6092[Abstract/Free Full Text]
  18. Kandror K, Pilch PF 1994 gp160–a novel tissue specific marker for insulin-activated glucose transport. Proc Natl Acad Sci USA 91:8017–8021[Abstract/Free Full Text]
  19. Kandror YU, Pilch PF 1994 The major protein of GLUT4-containing vesicles, gp160, has aminopeptidase activity. J Biol Chem 269:30777–30780[Abstract/Free Full Text]
  20. Keller SR, Scott HM, Mastick CC, Aebersold R, Lienhard GE 1995 Cloning and characterization of a novel insulin-regulated membrane aminopeptidase from Glut4 vesicles. J Biol Chem 270:23612–23618[Abstract/Free Full Text]
  21. Kandror KV, Coderre L, Pushkin AV, Pilch PF 1995 Comparison of glucose-transporter-containing vesicles from rat fat and muscle tissues: evidence for a unique endosomal compartment. Biochem J 307:383–390
  22. Coderre L, Kandror KV, Vallega G, Pilch PF 1995 Identification and characterization of an exercise-sensitive pool of glucose transporters in skeletal muscle. J Biol Chem 270:27584–27588[Abstract/Free Full Text]
  23. Ross SA, Scott HM, Morris NJ, Leung W-Y, Mao F, Lienhard GE, Keller SR 1996 Characterization of the insulin-regulated membrane aminopeptidase in 3T3–L1 adipocytes. J Biol Chem 271:3328–3332[Abstract/Free Full Text]
  24. Walker P, Ramlal T, Sarabia V, Koivisto U-M, Bilan PJ, Pessin JE, Klip A 1990 Glucose transport activity in muscle L6 cells is regulated by the coordinate control of subcellular glucose transporter distribution, biosynthesis, and mRNA transcription. J Biol Chem 265:1516–1523[Abstract/Free Full Text]
  25. Tsakiridis T, Vranic M, Klip A 1994 Disassembly of the actin network inhibits insulin-dependent stimulation of glucose transport and prevents recruitments of glucose transporters to the plasma membrane. J Biol Chem 269:29934–29942[Abstract/Free Full Text]
  26. Haney PM, Levy MA, Strube MS, Mueckler M 1995 Insulin-sensitive targeting of the GLUT4 glucose transporter in L6 myoblasts is conferred by its COOH-terminal cytoplasmic tail. J Cell Biol 129:641–658[Abstract/Free Full Text]
  27. Mitsumoto Y, Klip A 1992 Developmental regulation of the subcellular distribution and glycosylation of GLUT1 and GLUT4 glucose transporters in L6 muscle cells. J Biol Chem 267:4957–4962[Abstract/Free Full Text]
  28. Mitsumoto Y, Liu Z, Klip A 1993 Regulation of glucose and ion transporter expression during controlled differentiation and fusion of rat skeletal muscle cells. Endocr J 1:307–315
  29. Piper RC, Hess LJ, James DE 1991 Differential sorting of two glucose transporters expressed in insulin-sensitive cells. Am J Physiol 260:C570–C580
  30. Bilan PJ, Mitsumoto Y, Ramlal T, Klip A 1992 Acute and long-term effects of insulin-like growth factor I on glucose transporters in muscle cells. Translocation and biosynthesis. FEBS Lett 298:185–190[CrossRef][Medline]
  31. Douen AG, Burdett E, Ramlal T, Rastogi S, Vranic M, Klip A 1991 Characterization of glucose transporter-enriched membranes from rat skeletal muscle: assessment of endothelial cell contamination, and presence of sarcoplasmic reticulum and transverse tubules. Endocrinology 128:611–616[Abstract]
  32. Hundal HS, Marette A, Mitsumoto Y, Ramlal T, Blostein R, Klip A 1992 Insulin induces translocation of the {alpha}2 and ß1 subunits of the Na+/K+-ATPase from intracellular compartments to the plasma membrane in mammalian skeletal muscle. J Biol Chem 267:5040–5043[Abstract/Free Full Text]
  33. Ramlal T, Sarabia V, Bilan PJ, Klip A 1988 Insulin-mediated translocation of glucose transporters from intracellular membranes to plasma membranes: sole mechanism of stimulation of glucose transport in L6 muscle cells. Biochem Biophys Res Commun 157:1329–1335[CrossRef][Medline]
  34. Laemmli UK 1970 Cleavage of the structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685[CrossRef][Medline]
  35. Wilson CM, Mitsumoto Y, Maher F, Klip A 1995 Regulation of cell surface GLUT1, GLUT3, and GLUT4 by insulin and IGF-1 in L6 myotubes. FEBS Lett 368:19–22[CrossRef][Medline]



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Jiang, J. Fan, L. Bai, Y. Wang, Y. Chen, L. Yang, L. Chen, and T. Xu
Direct Quantification of Fusion Rate Reveals a Distal Role for AS160 in Insulin-stimulated Fusion of GLUT4 Storage Vesicles
J. Biol. Chem., March 28, 2008; 283(13): 8508 - 8516.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. C. Hou, N. Suzuki, J. E. Pessin, and R. T. Watson
A Specific Dileucine Motif Is Required for the GGA-dependent Entry of Newly Synthesized Insulin-responsive Aminopeptidase into the Insulin-responsive Compartment
J. Biol. Chem., November 3, 2006; 281(44): 33457 - 33466.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
L.-Z. Liu, H.-L. Zhao, J. Zuo, S. K.S. Ho, J. C.N. Chan, Y. Meng, F.-D. Fang, and P. C.Y. Tong
Protein Kinase C{zeta} Mediates Insulin-induced Glucose Transport through Actin Remodeling in L6 Muscle Cells
Mol. Biol. Cell, May 1, 2006; 17(5): 2322 - 2330.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E. D. Abel, C. Graveleau, S. Betuing, M. Pham, P. A. Reay, V. Kandror, T. Kupriyanova, Z. Xu, and K. V. Kandror
Regulation of Insulin-Responsive Aminopeptidase Expression and Targeting in the Insulin-Responsive Vesicle Compartment of Glucose Transporter Isoform 4-Deficient Cardiomyocytes
Mol. Endocrinol., October 1, 2004; 18(10): 2491 - 2501.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Shuralyova, P. Tajmir, P. J. Bilan, G. Sweeney, and I. R. Coe
Inhibition of glucose uptake in murine cardiomyocyte cell line HL-1 by cardioprotective drugs dilazep and dipyridamole
Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H627 - H632.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Zeigerer, M. A. Lampson, O. Karylowski, D. D. Sabatini, M. Adesnik, M. Ren, and T. E. McGraw
GLUT4 Retention in Adipocytes Requires Two Intracellular Insulin-regulated Transport Steps
Mol. Biol. Cell, July 1, 2002; 13(7): 2421 - 2435.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. R. Keller, A. C. Davis, and K. B. Clairmont
Mice Deficient in the Insulin-regulated Membrane Aminopeptidase Show Substantial Decreases in Glucose Transporter GLUT4 Levels but Maintain Normal Glucose Homeostasis
J. Biol. Chem., May 10, 2002; 277(20): 17677 - 17686.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Sumitani, K. Goya, J. R. Testa, H. Kouhara, and S. Kasayama
Akt1 and Akt2 Differently Regulate Muscle Creatine Kinase and Myogenin Gene Transcription in Insulin-Induced Differentiation of C2C12 Myoblasts
Endocrinology, March 1, 2002; 143(3): 820 - 828.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. A. Lampson, J. Schmoranzer, A. Zeigerer, S. M. Simon, and T. E. McGraw
Insulin-regulated Release from the Endosomal Recycling Compartment Is Regulated by Budding of Specialized Vesicles
Mol. Biol. Cell, November 1, 2001; 12(11): 3489 - 3501.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. S. Bogan, A. E. McKee, and H. F. Lodish
Insulin-Responsive Compartments Containing GLUT4 in 3T3-L1 and CHO Cells: Regulation by Amino Acid Concentrations
Mol. Cell. Biol., July 15, 2001; 21(14): 4785 - 4806.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Yu, E. Blomstrand, A. V. Chibalin, H. Wallberg-Henriksson, J. R. Zierath, and A. Krook
Exercise-associated differences in an array of proteins involved in signal transduction and glucose transport
J Appl Physiol, January 1, 2001; 90(1): 29 - 34.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Subtil, M. A Lampson, S. R. Keller, and T. E. McGraw
Characterization of the Insulin-regulated Endocytic Recycling Mechanism in 3T3-L1 Adipocytes Using a Novel Reporter Molecule
J. Biol. Chem., February 18, 2000; 275(7): 4787 - 4795.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Garza and M. J. Birnbaum
Insulin-responsive Aminopeptidase Trafficking in 3T3-L1 Adipocytes
J. Biol. Chem., January 28, 2000; 275(4): 2560 - 2567.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Lampson, A Racz, S. Cushman, and T. McGraw
Demonstration of insulin-responsive trafficking of GLUT4 and vpTR in fibroblasts
J. Cell Sci., January 11, 2000; 113(22): 4065 - 4076.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
Z. Khayat, P Tong, K Yaworsky, R. Bloch, and A Klip
Insulin-induced actin filament remodeling colocalizes actin with phosphatidylinositol 3-kinase and GLUT4 in L6 myotubes
J. Cell Sci., January 1, 2000; 113(2): 279 - 290.
[Abstract] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Ueyama, K. L. Yaworsky, Q. Wang, Y. Ebina, and A. Klip
GLUT-4myc ectopic expression in L6 myoblasts generates a GLUT-4-specific pool conferring insulin sensitivity
Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E572 - E578.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Zhou, L. Sevilla, G. Vallega, P. Chen, M. Palacin, A. Zorzano, P. F. Pilch, and K. V. Kandror
Insulin-dependent protein trafficking in skeletal muscle cells
Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E187 - E196.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. O. Johnson, A. Subtil, R. Petrush, K. Kobylarz, S. R. Keller, and T. E. McGraw
Identification of an Insulin-responsive, Slow Endocytic Recycling Mechanism in Chinese Hamster Ovary Cells
J. Biol. Chem., July 10, 1998; 273(28): 17968 - 17977.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. V. Sandoval, S. Martinez-Arca, J. Valdueza, S. Palacios, and G. D. Holman
Distinct Reading of Different Structural Determinants Modulates the Dileucine-mediated Transport Steps of the Lysosomal Membrane Protein LIMPII and the Insulin-sensitive Glucose Transporter GLUT4
J. Biol. Chem., December 15, 2000; 275(51): 39874 - 39885.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Suarez, D. Bach, J. Cadefau, M. Palacin, A. Zorzano, and A. Guma
A Novel Role of Neuregulin in Skeletal Muscle. NEUREGULIN STIMULATES GLUCOSE UPTAKE, GLUCOSE TRANSPORTER TRANSLOCATION, AND TRANSPORTER EXPRESSION IN MUSCLE CELLS
J. Biol. Chem., May 18, 2001; 276(21): 18257 - 18264.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sumitani, S.
Right arrow Articles by Klip, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sumitani, S.
Right arrow Articles by Klip, A.


HOME